| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5203522
Max Phase: Preclinical
Molecular Formula: C19H15ClN4O3
Molecular Weight: 382.81
Associated Items:
Representations
Canonical SMILES: COc1ccc(-c2nnc(-c3cc(Cl)ccc3-c3cn[nH]c3)o2)cc1OC
Standard InChI: InChI=1S/C19H15ClN4O3/c1-25-16-6-3-11(7-17(16)26-2)18-23-24-19(27-18)15-8-13(20)4-5-14(15)12-9-21-22-10-12/h3-10H,1-2H3,(H,21,22)
Standard InChI Key: GOSZOBCGZUABOQ-UHFFFAOYSA-N
Associated Targets(Human)
Metabotropic glutamate receptor 7 376 Activities
Associated Targets(non-human)
Metabotropic glutamate receptor 7 580 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 382.81 | Molecular Weight (Monoisotopic): 382.0833 | AlogP: 4.46 | #Rotatable Bonds: 5 |
| Polar Surface Area: 86.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.26 | CX LogP: 3.24 | CX LogD: 3.24 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -1.05 |
References
| 1. Reed CW, Rodriguez AL, Kalbfleisch JJ, Seto M, Jenkins MT, Blobaum AL, Chang S, Lindsley CW, Niswender CM.. (2022) Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro., 74 [PMID:35944850] [10.1016/j.bmcl.2022.128923] |
Source
Source(1):